Herlyn
Herlyn is Neratinib Maleate, an irreversible pan-HER tyrosine kinase inhibitor. It is indicated for HER2-positive breast cancer, including extended adjuvant settings and works by blocking HER family signaling pathways involved in tumor progression.
Features
| Product Name | Herlyn |
| Generic Name | Neratinib Maleate |
| Formulation | Tablet |
| Available Pack Size | 1X30's |
| Available Strength | 40 mg |